Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02681549
Title Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

melanoma

lung non-small cell carcinoma

Therapies

Bevacizumab + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Smilow Cancer Hospital at Yale New Haven Recruiting New Haven Connecticut 06510 United States Details
Moffitt Cancer Center Recruiting Tampa Florida 33612 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field